Eurozone carnage: Is investing in European funds now a

New Post Public Reply Private Reply Replies (0) Message Board
Stock Buff

Eurozone carnage: Is investing in European funds now a bargain, or too toxic to touch?

By Tanya Jefferies

|

European funds have suffered brutal losses and huge outflows as the debt crisis rages on the continent.

Greece is on the brink of crashing out of the euro, Spain's banking system may collapse under the weight of bad loans, and the leaders of Germany and France are bitterly divided over how to stave off a financial catastrophe.

Unsurprisingly, investors continue to flee the scene of carnage. But we are always told you should buy when others are most fearful, so does that make this a buying opportunity in European stocks?

Euro clash: Greek firebrand leftist Alexis Tsipras is challenging German chancellor Angela Merkel's 'austerity' solution to the debt crisis
Euro clash: Greek firebrand leftist Alexis Tsipras is challenging German chancellor Angela Merkel's 'austerity' solution to the debt crisis

Euro clash: Greek firebrand leftist Alexis Tsipras is challenging German chancellor Angela Merkel's 'austerity' solution to the debt crisis

A 'no-go zone' for investors

Phillipa Gee: 'Foolhardy to invest in European funds now'

Phillipa Gee: 'Foolhardy to invest in European funds now'

It's foolhardy to invest in European funds now.

That is the view of Philippa Gee, of Philippa Gee Wealth Management, who doesn't recommend any European funds at present.

'We don't know where the contagion will end. Unfortunately I don't feel it's over yet,' she says.

'I have some people saying to me I want to get into Europe because there might be an opportunity at this point. My view is that we are not at that point yet.

'I just think there is so much risk in the markets generally and most investments are relatively adverse at the moment. Why set yourself up for disaster?

'I am not writing it off permanently but I feel that it's foolhardy to invest in European funds now.'

Gee points out that we are in such uncharted territory that we don't even know what currency companies will be trading in on the other side of the crisis.

It's simply 'a no-go zone' right now, she believes.

 

Meanwhile, investors who bought into European funds when they were popular about 10 years ago need to consider carefully whether it is still worth hanging on and risking further losses.

'Further falls are entirely likely,' says Gee. 'Either get out and accept losses or have a long-term view.'

Although she declines to offer any European fund tips, Gee does suggest that opportunity seekers look at global growth funds.

These might have low European holdings at present but managers will raise them when the single currency crisis does start to subside.

'Don't think that you have to make these asset allocation decisions yourself,' says Gee. 'If you don't want to make that judgement yourself go for a global fund where a manager does it.'

Gee recommends: Jupiter Merlin Worldwide Portfolio . Total expense ratio - 2.56 per cent.

(TER is the benchmark of fund running costs which is the current best estimate for taking all the administration and dealing charges into account. The bigger it is, the costlier the fund is to run.)

LOW-COST ACCESS TO EUROPEAN INVESTING

Actively-managed funds need to pay a fund manager to select stocks, pushing up the costs. Index trackers, on the other hand, aim to follow a stock market's fortunes based on a computer programme.

It's far cheaper. The best trackers levy fees of less than 0.5% a year compared to, for example, the Jupiter Merlin fund that has a total expense ratio (TER) of more than 2.5%.

These effect of charges amplifies over the years and can leave a big dent in your final savings pot, although the managers argue that you are paying for their skill in outperforming the market. Unfortunately most of them don't and it's difficult to predict which ones will excel.

As for cheap trackers, £1.6billion of investors' money is currently parked in L&G's European tracker, but with an annual fee of 0.65% (total expense ratio of 0.84%), those savers would be wise to move to M&G's fund - 0.5% (0.69% TER) - or the even cheaper HSBC tracker at 0.25% (0.31% TER) or Vanguard's, also at 0.25%.

Investors could also consider exchange-traded funds (ETFs), which are more easily tradable and are sometimes cheaper than trackers.

DB X-trackers has a Euro Stoxx 50 ETF , which charges 0.1% and currently pays an income yield of nearly 4 per cent.

'Eurobonds' could spark market rally

Mick Gilligan: 'Valuations in Europe do look particularly low'

Mick Gilligan: 'Valuations in Europe do look particularly low'

'In terms of where we are now valuations in Europe do look particularly low. That is not to say they can't go lower,' says Mick Gilligan, head of research at independent investment adviser Killik & Co.

Individual or 'retail' investors have sold off European equities, which has resulted in big flows out of open-ended funds, while investment trusts are trading at discounts of around 11 per cent, he explains.

Gilligan says the eurozone crisis is the dominant factor in any form of global investing right now. But the prospect of economic contraction in euro member countries means the companies most exposed to them are bearing the brunt of the sell-off.

'People don't want to hold anything in this space,' he says.

That goes for large cap and small cap firms - there has been selling across the board.

Nevertheless, Gilligan believes a eurozone scenario where the single currency countries 'muddle through' with the help of a guarantee on European banks is growing more likely.

He reckons 'eurobonds' - a French-backed idea which would see joint eurozone bonds issued to ease borrowing costs for weaker member countries - are unlikely to materialise.

'If we get eurobonds markets will take off big time, I think. But the other scenario is Germany stalls and says they are not willing to underwrite other countries.'

Right now, his preference in European funds is for those taking short positions [anticipating share falls] as well as long positions [anticipating share rises] in European companies. He tips Ennismore European Smaller Companies in this space.

He also likes Schroder European Alpha Plus, which has holdings in Swiss - in other words, not eurozone-based - companies such as Nestle, Novartis and Syngenta. The fund tends to be invested in firms with quite a bit of exposure to markets outside the eurozone, says Gilligan.

Gilligan recommends: Ennismore European Smaller Companies (TER 2.35 per cent) and Schroder European Alpha Plus (TER 1.67 per cent),

'There could be more blood'

Darius McDermott: 'There could be more blood'

Darius McDermott: 'There could be more blood'

European funds have mirrored the wider turmoil on the continent, says Darius McDermott of independent adviser Chelsea Financial Services.

He reels off one-year figures which reveal how European equity markets have underperformed other global markets.

The average North America fund is up 0.2 per cent while the average UK fund is off 6 per cent - but European funds are 19.1 per cent lower and European smaller company funds are down 15.7 per cent.

'More than anything markets hate uncertainty. The markets are very uncertain about which way Europe is going,' says McDermott.

That does makes Europe a bargain - the trouble is there's a definite possibility it will become even more of a bargain. That means, says McDermott: 'There could be more blood.'

And he adds: 'They say buy when fear is at its greatest. Fear is high but not at its greatest.'

He says if someone wants to invest £10,000 in European equities now, he would advise them to 'drip in not pile in'.

McDermott recommends: BlackRock Continental Europe (TER 1.67 per cent) and Argonaut European Alpha (TER 1.78 per cent),

Enlarge European fund performance over five years (Source: FE data)

European fund performance over five years (Source: FE data)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Embraer ADS Ratio Change: Impact on Investors

Updated Category News Views 5

ADS Ratio Adjustments: What's the Big Deal? Well, here we go. Embraer, that Brazilian aerospace heavyweight, has just kicked up some dust with its latest move concerning American Depositary Shares (ADS). Now, don't expect any shock and awe value-explosion gimmicks, but there's a shift in the air. Understanding the Split Let's cut to the financial meat: Embraer’s mucking...

Continue Reading
Anguilla Culinary Festival 2027: A Feast Beyond Food

Updated Category News Views 73

A Culinary Quest in the Caribbean Imagine this: a culinary pilgrimage where the Caribbean’s essence is served on a plate. The Anguilla Culinary Experience (ACE), set for April 28 through May 2, 2027, isn't just about stretching waistbands. It’s about embracing the spirit and flavors of Anguilla, one of the world's cherished culinary hotspots. Cooking with Purpose ACE...

Continue Reading
Cousins Lobster Hits Arkansas for Tasty Pop-Up Tour

Updated Category News Views 30

A New England Delicacy Rolling into Arkansas Folks in Northwest Arkansas are about to get a bite of the coast, and it's a big deal for any foodie out there who craves that authentic, no-frills lobster experience. Cousins Maine Lobster is setting out on a pop-up tour—a whirlwind of five days from November 11-15—bringing their joy-inducing lobster rolls straight from...

Continue Reading
Omaha Steaks Simplifies Gifting with Delicious Solutions

Updated Category News Views 39

Who’s got time to fuss over the perfect holiday gift? Turns out, just about nobody. A recent survey suggests 79% of adults over 25 yearn to ditch the guessing games when it comes to gifting. Enter Omaha Steaks, staking its claim as the hero of culinary generosity. Eating Up the Holiday Stress This isn't just your average foodie fare. Omaha Steaks has cooked up a plan...

Continue Reading
TXNM Energy's Q3 2026 Hits Hard Amid Heat and M&A

Updated Category News Views 9

TXNM Energy: A Strong Q3 2026 Amid Acquisition Waves Every so often, a company struts into earnings season and lays all its cards on the table. TXNM Energy just did that for Q3 2026, showing some robust numbers and setting tongues wagging on Wall Street. With GAAP earnings per diluted share shooting up to $1.50 from $1.22 the previous year, it's clear the power play is...

Continue Reading
FirstEnergy Bolsters Support for Shelter Initiatives

Updated Category News Views 96

FirstEnergy Foundation's Commitment Shines Bright Alright, here's the scoop. FirstEnergy Foundation isn't just about keeping the lights on anymore. They're throwing down $620,000 to tackle one hell of a tough nut—shelter and stability. This latest infusion spreads across five states, with ten nonprofit warriors in New Jersey alone locking in $120,000 of that pot for...

Continue Reading
ATTACK SHARK's X60: A New Era in Gaming Audio

Updated Category News Views 58

Gaming Audio Gets a Power Boost with X60 We're diving headfirst into an era where gaming headsets promise more bells and whistles than ever before. This isn't just some random gadget plopped on the market. ATTACK SHARK's X60 Gaming Headset is strutting in, guns blazing, ready to take on the heavyweights in the competitive gaming world. It's not just about being another...

Continue Reading
Transforming Healthcare Leadership Through Systemic Change

Updated Category News Views 15

Reframing Physician Leadership for Systemic Transformation Here we go, diving into some serious change-making in the healthcare sphere. If you've ever wandered through a hospital corridor, you've likely felt the tension between docs and the suits. The American Association for Physician Leadership (AAPL) is stirring the pot with a fresh book that might just be the catalyst...

Continue Reading
NeuroSense's Phase 3 Strategies for PrimeC Unveiled

Updated Category News Views 79

How NeuroSense Is Poised to Tackle ALS Treatment Picture this: a room full of people holding their breath, hoping that NeuroSense can deliver the breakthrough they’ve been inching toward. It’s the kind of moment that gives you goosebumps if you've been sloggin' through the biotech trenches. NeuroSense’s pitch at NEALS is more than just a dog and pony show—it's a...

Continue Reading
Cohere's CAD $7 Billion Raise Signals AI Power Shift

Updated Category News Views 149

Changing the Game: Cohere's Massive Series E Raise There's a seismic shift happening up north, and it’s not the aurora borealis. Cohere just announced the initial close of a staggering CAD $7 billion Series E funding round, eyeing a CAD $35.7 billion valuation. If it pans out, it’d be the kind of cash grab that's never been seen in Canadian tech history. Why This...

Continue Reading

Top 5 Most Recently Viewed Articles

Hewlett Packard Enterprise and Juniper Networks Stand Firm on Merger

Updated Category News Views 120

Hewlett Packard Enterprise and Juniper Networks Stand Firm Hewlett Packard Enterprise (NYSE:HPE) and Juniper Networks, Inc. (NYSE:JNPR) have publicly expressed their strong disapproval regarding the U.S. Department of Justice's recent move to block their impending acquisition. Both companies assert that the government's position is fundamentally misguided and look forward...

Continue Reading
Essity's Strategic Repurchase of Class B Shares Explained

Updated Category News Views 65

Essity’s Class B Shares Buyback Overview Recently, Essity Aktiebolag declared its intention to repurchase a significant quantity of its Class B shares. This initiative reflects the company's commitment to enhance its shareholders' value while efficiently managing capital allocation. The buyback program announced earlier provides a structured approach aimed at achieving...

Continue Reading
24 Seven Achieves Recognition on Forbes 2025 List of Best Firms

Updated Category News Views 253

24 Seven Achieves Recognition on Forbes 2025 List of Best Firms 24 Seven, a leading firm in the marketing, creative, and digital talent solutions space, has once again made waves in the industry by appearing on the prestigious list of America’s Best Recruiting and Temporary Staffing Firms for 2025. This significant recognition highlights the exemplary standards...

Continue Reading
Valneva's Chikungunya Vaccine Sees Strong Results in Children

Updated Category News Views 148

Positive Results from Valneva's Chikungunya Vaccine Trial Valneva SE (NASDAQ: VALN; Euronext Paris: VLA), a leading specialty vaccine company, has reported encouraging findings from its Phase 2 clinical trial for its chikungunya vaccine, IXCHIQ. This trial focused on assessing the safety and immunogenicity of two distinct dose levels of this single-shot vaccine among...

Continue Reading
Recognizing Trailblazers: 2025 WISE Awards Nominations Open

Updated Category News Views 368

Nominations Open for 2025 WISE Awards by Smart Energy Decisions Smart Energy Decisions (SED), a pivotal professional network focused on empowering businesses to make informed energy choices, has officially opened the nominations for the esteemed 2025 WISE (Women in Smart Energy) Awards. These awards aim to honor the groundbreaking contributions of women in the energy...

Continue Reading